| Old Articles: <Older 21141-21150 Newer> |
|---|
 |
The Motley Fool
February 28, 2007
Emil Lee |
Pinnacle Airlines Grounded: Fool by Numbers The airline released fourth-quarter and full-year 2006 earnings: Income Statement Highlights... Margin Checkup... Management Effectiveness... Balance Sheet Highlights... Cash Flow Highlights...   |
The Motley Fool
February 28, 2007 |
Stop and Go at AutoZone: Fool by Numbers The auto parts retailer released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Management Effectiveness... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
February 28, 2007
Brian Lawler |
Dynavax Down but Not Out Drug developer Dynavax gives guidance for 2007 after its lead drug candidate fails in clinical testing. |
The Motley Fool
February 28, 2007
Rick Aristotle Munarriz |
Great Wolf Uncaged The family resort specialist is winning back guests. All Great Wolf can do for now is keep its hotel guests happy and its shareholders happier. Unfortunately, the near-term outlook won't set investors' hearts aflutter. |
The Motley Fool
February 28, 2007 |
Cox Coming in Fuzzy: Fool by Numbers The radio station operator released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Management Effectiveness... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
February 28, 2007 |
Sirius Popped the Question: Fool by Numbers The satellite radio provider released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Management Effectiveness... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
February 28, 2007
Brian Lawler |
Alpharma's Just All Right Drugmaker Alpharma announces its fourth-quarter financial results and reiterates guidance for 2007. |
The Motley Fool
February 28, 2007
Brian Lawler |
Discovery Prepares for Its Fate Discovery Labs announces its quarterly financial results as it prepares for another meeting with the FDA. Investors, take note. |
The Motley Fool
February 28, 2007
Brian Lawler |
Threshold Over the Edge Another day, another development-stage drugmaker implodes. Investors, Threshold announced negative clinical trial results for its lead drug. |
The Motley Fool
February 28, 2007
Chuck Saletta |
Get the World's Best Job To put it simply: You buy shares in great companies, and then they pay you in dividends. Some of the world's most well-known firms are on the list -- BP... Citigroup... PepsiCo... etc. |
| <Older 21141-21150 Newer> Return to current articles. |
